Tuoxin Pharmaceutical Group Co Ltd has made a strategic investment in Jiangsu Jinsan Biotechnology, acquiring a 1.75% equity stake in a move to expand its presence in the pharmaceutical and biotechnology sectors.

Tuoxin Pharmaceutical Group Co Ltd is a significant player in China’s pharmaceutical industry, with a promising trajectory and substantial economic influence.

Tuoxin Pharmaceutical Group Co Ltd is planning a significant asset restructuring, amidst a dynamic market environment with strong performance in the pharmaceutical sector, and will resume trading on May 19, 2025.

Tuoxin Pharmaceutical Group Co Ltd’s stock price has fluctuated over the past year, with a current market capitalization of 3.3 billion CNY, reflecting the company’s dynamic market position and potential for growth.